{"schema_version":"secwatch.filing_event.v1","accession":"0001588978-23-000019","form_type":"8-K","ticker":"PRCT","cik":"0001588978","company_name":"PROCEPT BioRobotics Corp","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.451517+00:00","generated_at":"2026-06-13T00:31:19.437158+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PROCEPT BioRobotics Q2 revenue $33.1M (+98% YoY); raises FY2023 guidance to $131M","bullets":["Record 40 U.S. AquaBeam systems sold in Q2; U.S. system revenue $14.8M (+74% YoY).","U.S. handpiece & consumables revenue $13.6M (+138% YoY); utilization per account up 9%.","Gross margin 56% (vs 51% prior year); narrowed net loss $25.3M vs $19.2M.","FY2023 revenue guidance raised to $131M (from $128M); gross margin ~55% (from ~54%).","United Healthcare issued positive coverage policy for Aquablation, effective June 1, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001588978-23-000019","json":"https://secwatch.observer/filing/0001588978-23-000019.json","markdown":"https://secwatch.observer/filing/0001588978-23-000019.md","text":"https://secwatch.observer/filing/0001588978-23-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/prct-20230727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T00:31:19.437158+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c1962ecca97ecbe62584afba87a0c68c39fb848","claim":"PROCEPT BioRobotics Corp reported quarter ended June 30, 2023 results: net income -$25.3 million.","evidence_excerpt":"Total revenue for the second quarter of 2023 was $33.1 million, an increase of 98% compared to the prior year period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended June 30, 2023"},{"label":"Net income","value":"-$25.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"1c1962ecca97ecbe62584afba87a0c68c39fb848","claim":"PROCEPT BioRobotics Corp reported quarter ended June 30, 2023 results: net income -$25.3 million.","evidence_excerpt":"Net loss was $25.3 million for the second quarter of 2023, compared to a loss of $19.2 million in the prior year period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended June 30, 2023"},{"label":"Net income","value":"-$25.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"64ce1369ee5cb10fbda77b5c4976352004b48720","claim":"PROCEPT BioRobotics Corp reported full year 2023 results: revenue $131 million. Guidance raised.","evidence_excerpt":"The Company projects revenue for the full year 2023 to be approximately $131 million, which represents 75% growth over the Company’s prior year revenue. This compares to previous revenue guidance of $128 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"$131 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}